MAPT and frontotemporal dementia: Third, baseline tau PET positivity in cognitively impaired participants did not guarantee a diagnosis of AD dementia at follow up: one participant was assessed to be cognitively normal at follow up even under these circumstances and another was reassessed to have FTD.